Kidney Allograft Rejection

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2025-11-20
Clinical Trial Update: Eculizumab Therapy for Subclinical Antibody-mediated Rejection in Kidney Transplantation [Phase 1, Phase 2]
A Phase 1/2 trial evaluating eculizumab for subclinical acute antibody-mediated rejection in kidney transplantation has been withdrawn.